Severe drug-induced agranulocytosis successfully treated with recombinant human granulocyte colony-stimulating factor

2Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

When elderly patients are prescribed many different medications, the risk for developing serious adverse events should be kept in mind. One of these adverse events is agranulocytosis, which, although rare, can be life-Threatening if left untreated. The majority of agranulocytosis cases are caused by drugs, including antibiotics. Here, we report a case of severe agranulocytosis in a 96-year-old woman following antibiotic therapy which was successfully managed using recombinant human granulocyte colony-stimulating factor (rhG-CSF) and the appropriate choice of antibiotics to treat her concomitant infection.

Cite

CITATION STYLE

APA

Kubota, Y., & Wong, T. Y. E. (2018). Severe drug-induced agranulocytosis successfully treated with recombinant human granulocyte colony-stimulating factor. Case Reports in Medicine, 2018. https://doi.org/10.1155/2018/8439791

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free